Clinical Trials · NCT04893148
Efficacy and Safety of iGlarLixi Versus Insulin Glargine Plus Dulaglutide in Patients With Type 2 Diabetes
- Phase
- Phase 4
- Recruitment status
- Unknown
- Sponsor
- Chungbuk National University Hospital
- Enrollment
- 40
- Start date
- May 2020
- Locations
- 1 site, South Korea
- Primary endpoint
- Changes in glycated hemoglobin (HbA1c)